Stay updated on FX-322 Safety Study in Cochlear Implantation Clinical Trial

Sign up to get notified when there's something new on the FX-322 Safety Study in Cochlear Implantation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FX-322 Safety Study in Cochlear Implantation Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the FX-322 concentration in cochlear fluid (perilymph) in the phase 1 safety study of FX-322 in adults undergoing cochlear implantation.
    Difference
    0.2%
    Check dated 2024-06-06T14:39:29.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that male or female adult subjects with severe to profound sensorineural hearing loss are eligible. It also outlines specific inclusion and exclusion criteria for participants.
    Difference
    18%
    Check dated 2024-05-22T21:16:55.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:14:40.000Z thumbnail image

Stay in the know with updates to FX-322 Safety Study in Cochlear Implantation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FX-322 Safety Study in Cochlear Implantation Clinical Trial page.